UNIT 4 - DIAGRAMS Flashcards

1
Q

High hydrolytic resistance

  • More chemically inert than the soda-lime glass.

Alkalinity is removed by using boric oxide to neutralize the oxides of potassium and sodium

  • contain strong acid and alkalis as well as all types of solvent
  • used for parenteral preparation
  • Buffered and unbuffered aqueous solutions.
A

HIGHLY RESISTANT BOROSILICATE GLASS
(USP TYPE I)

*powdered glass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • High hydrolytic resistance
  • Made of commercial soda lime glass
  • De-alkalized or treated to remove surface alkali (Sulphur treatment-___________/_________).
  • Suitable for acidic and neutral aqueous preparations
  • Buffered aqueous solution with pH below 7 (parenteral preparation)
A

sulphur dioxide/ammonium sulphate

TREATED SODA-LIME GLASS
(USP TYPE II)
* water attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • Moderate hydrolytic resistance
  • Untreated made of commercial soda lime glass
  • It is an alkaline glass having high percentage of ______ and ______ and no __________
  • Suitable for non-aqueous
    preparations
  • (Dry powder and _________ solution)

Limitation = Not generally used for parenteral preparations

A
  • lime and soda
  • boric oxide
  • oleaginous

SODA-LIME GLASS
(USP TYPE III)
* powdered glass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • has similar composition to that of type III glass but there is no guarantee of similar properties
  • Supplied for Non-parenteral products
  • (Tablet, Oral or Topical use)
  • Limitation = Not used for parenteral preparations
A

GENERAL PURPOSE SODA-LIME GLASS
(USP TYPE IV NP)
* powdered glass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

types of water for pharmaceutical use

A
  1. purified water USP
  2. water for injection
  3. sterile water for injection
  4. bacteriostatic water for injection
  5. sterile water for inhalation
  6. sterile water for irrigation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  • Prepared by distillation reverse osmosis & same time lon-exchange.
  • Used as a solvent in all pharmaceutical preparation except parenteral sterile preparation.
  • Also used for all tests & assays of the IP, unless otherwise specified
  • Hand washing (in the sterile production)
A

purified water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • Pyrogen free only ((not more than 0.25 IU of endotoxin per ml)
  • Used as a solvent in parenteral preparation

Note: it is not intended to be sterile but should comply with the test for a limit of Endotoxin (Pyrosen free). i.e

it is pyrogen-free but not sterilized as per IP.

  • Not contain an added substance
A

WATER FOR INJECTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • Sterilised & packed in a single-dose glass container of type
    I & II;
  • maximum. of 1 (one) Litre capacity. i.e both pyrogen-free and sterilized
  • Used as a solvent for powder or Injection.

-Not contain an added substance

A

SWFI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • Sterile WFI contains one or more suitable Bacteriostatic agents & packed in a single or multiple-dose glass container & Maximum 30 mL capacity.
  • Contain added substance
A

BWFI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • it is WFI (Sterilised) & free from an endotoxin
  • used in the test for Bacterial Endotoxin (Pyrogen) Test.
A

water BET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • Distilled water filtered through 0.45m membrane & Conductivity
    not more than 0.15 S/cm @ 25 degrees centigrade.
A

highly purified water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

drug discovery and development process

A
  1. drug discovery
  2. preclinical development
  3. clinical development
    - phase I
    - phase II
    - phase III
  4. regulatory approval
  5. phase IV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • Target selection
  • Lead-finding
  • Lead optimisation
  • Pharmacological profiling
A

DRUG DISCOVERY

2.5 years
100 projects

10, 000 compounds screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • pharmacokinetics
  • short-term toxicology
  • formulation
  • synthesis scale-up

______: in glass
______: in the living

A

PRECLINICAL DEVELOPMENT

1.5 years
20 compounds

in vitro (cells/molecules)
in vivo (animals)

required standard: 2 mammalian species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • pharmacokinetics
  • tolerability
  • side-effects in healthy volunteers
A

PHASE 1 CLINICAL DEVELOPMENT

5-7 years
10

usually 20-80 people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • small-scale trials in patients to assess efficacy and dosage
  • long-term toxicology studies
A

PHASE II CLINICAL DEVELOPMENT

5-7 years
5

usually 100-300 people

17
Q
  • large scale controlled clinical trials
A

PHASE III CLINICAL DEVELOPMENT

5-7 years
2

usually 1000-3000 people

18
Q
  • submission of full date and review by regulatory agencies
A

REGULATORY APPROVAL

1.2 years
1.2

19
Q
  • postmarketing surveillance
A

PHASE IV

1